Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05539976 · ClinicalTrials.gov registry record
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
A clinical trial of Healthy Participants, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT05539976 is a study of Healthy Participants that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 10 participants, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05539976, a study of Healthy Participants, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.
Conditions Studied
Study Locations (1)
Massachusetts
- Local Institution - 0001 - Woburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2022-11-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05539976
The ClinicalTrials.gov registry entry for NCT05539976 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (85% lower). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 0 interventions.
NCT05539976 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05539976 about?
NCT05539976 is a clinical study titled "A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants". The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.
What is the current status of trial NCT05539976?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-09-30. Estimated completion is 2022-11-14.
What conditions does trial NCT05539976 study?
This clinical trial studies the following conditions: Healthy Participants.
Who is sponsoring clinical trial NCT05539976?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05539976 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
RECRUITING · Phase 1
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
RECRUITING · Phase 1
-
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
RECRUITING · Phase 1
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.